A common drug used for inflammatory skin conditions may hold the key to treating both alcohol addiction and pain sensitivity.

A research team from Virginia Commonwealth University has found that a drug currently in clinical trials for brain disorders ...

When flibanserin was approved, it came with a boxed warning about hypotension and syncope in women taking the drug after drinking alcohol, which had been seen in the product's clinical trials ...

Clearmind Gains IRB Approval At TASMC For Alcohol Use Disorder Drug Trial July 03, 2025 — 01:23 pm EDT Written by RTTNews.com for RTTNews -> ...

Explore the intersection of mental health and drug abuse in Black communities, highlighting the stigma and barriers to seeking treatment.

Dr. Santina Wheat, Family Medicine Physician at Northwestern Medicine Delnor Hospital in Geneva joins Bob Sirott to cover a ...

Altimmune is a late clinical-stage biopharmaceutical company focused on developing novel peptide-based therapeutics for liver and cardiometabolic diseases. The Company’s lead program is pemvidutide, a ...

Clearmind Medicine Inc. (Nasdaq: CMND), (FSE: CWY0) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on discovery and development of novel psychedelic-derived therapeutics to ...